Risk for obesity higher for children in areas of low socioeconomic status
THURSDAY, Jan. 5, 2023 (HealthDay News) — There was an increase in body mass index (BMI) in 3- and 4-year-olds in Sweden during the COVID-19 pandemic, according to a study published online Dec. 8 in the European Journal of Public Health.
Anna Fäldt, M.D., from Uppsala University in Sweden, and colleagues examined changes in BMI among preschool children in Sweden before and during the COVID-19 pandemic in a retrospective population-based cross-sectional study. Data were included for 25,049 children from three Swedish regions, with growth measures at 3, 4, and 5 years of age (16,237, 14,437, and 11,711 children, respectively).
The researchers found that during the COVID-19 pandemic, there was a significant increase in BMI in children aged 3 and 4 years. In 3-year-old girls, obesity increased from 2.8 to 3.9 percent. Increases in obesity and overweight (girls) were seen in 4-year-olds, while the prevalence of underweight decreased among boys. In 5-year-olds, there was no change noted in BMI. A higher risk for obesity was seen for children in areas of low socioeconomic status.
“Although Sweden didn’t have a lockdown in the same way as many other countries during the pandemic, the incidence of overweight and obesity increased in 3- and 4-year-olds, and even at such a young age, the socioeconomic differences are evident,” a coauthor said in a statement. “The study highlights the need for further efforts and interventions aimed at preventing childhood obesity, especially in areas of lower socioeconomic status.”
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths
Obesity Has Increased Significantly in U.S. Adults and Youths Since 1999
Predictors of Prediabetes/T2DM Identified Among U.S. Adolescents
In Pediatric Leukemia, Survival Linked to Duration of Overweight, Obesity
All-Cause Mortality Elevated for Adult Five-Year Survivors of Hodgkin Lymphoma
Acute Myeloid Leukemia Increasingly Impacting Older Adults Globally
Achieving PSA <0.2 ng/mL Improves Survival in Metastatic Castration-Sensitive Prostate Cancer
Cancer-Attributable Costs High for Seniors, Vary With Cancer Phase, Type, Race